A phase I first-in-patient study of rucaparib in patients with solid tumours.
Phase of Trial: Phase I
Latest Information Update: 26 Nov 2015
At a glance
- Drugs Rucaparib (Primary) ; Temozolomide
- Indications Malignant melanoma; Solid tumours
- Focus Adverse reactions; First in man; Pharmacodynamics; Pharmacokinetics
- 26 Nov 2015 New trial record